BMEA
Biomea Fusion, Inc. · Healthcare
A2A Pharmaceuticals, Inc. sold $389K of Biomea Fusion, Inc.
10% owner
Sold$388,516
$11.21Price
34,658Shares
−1%Stake
What BMEA did after the filing
- The stock from Mon, Jul 25 close, $11.04
- +11.1%
- S&P 500, same days
- −1.2%
Measured over 30 trading days, to the Sep 6 close.
Traded Thu, Jul 21. Filed Mon, Jul 25, 3:16 PM ET, during the session. Returns use the Jul 25 close and the Sep 6 close. Not investment advice.